Making the right decision about weight loss, whether through lifestyle change or medical support, starts with expert evaluation
When you inject semaglutide or tirzepatide, virtually all of the medication enters your system and gets to work
GLP-1 RAs have been found to improve body weight, blood pressure (BP), lipid profile levels, and myocardial infarction (MI) outcomes even in nondiabetic patients without increasing the risk of hypoglycemic events ( Our narrative review aimed to discuss the CV benefits of GLP-1 RAs in terms of controlling CV risk factors and improving HF outcomes, and the CV perspectives related to their use in clinical practice
Our certified clinicians provide peptide treatments including healing peptides, growth hormone secretagogues, metabolic enhancers, and anti-aging compounds
The first is the GLP-1 receptor , which most people recognize from semaglutide and other incretin-based therapies
For datasets with overlapping populations, we ensured that only the non-overlapping subset was included in the meta-analysis to avoid duplication bias